Manufacturer
Padagis
Pharmaceutical manufacturer based in United States
United States
- Products listed
- 49
- Molecules
- 29
- Therapy areas
- 11
Padagis is a pharmaceutical manufacturer based in United States. MedsAcross lists 49 of its products across 29 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United States
- Indian manufacturer
- No
- Also listed as
- Padagis Us LLC, Padagis US LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Padagis products through licensed channels, with the documents your regulator needs.
Psychiatry
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Compro 25 mg suppositoryRectal | Prochlorperazine | US FDA | Available on request |
| Methylphenidate 27.5 mg/mg transdermal patchTransdermal Cold chainGeneric name | Methylphenidate | US FDA | Available on request |
| Methylphenidate 41.3 mg/mg transdermal patchTransdermal Cold chainGeneric name | Methylphenidate | US FDA | Available on request |
| Methylphenidate 55 mg/mg transdermal patchTransdermal Cold chainGeneric name | Methylphenidate | US FDA | Available on request |
| Methylphenidate 82.5 mg/mg transdermal patchTransdermal Cold chainGeneric name | Methylphenidate | US FDA | Available on request |
| Midazolam 2 mg/mL syrupOralGeneric name | Midazolam | US FDA | Available on request |
| Paroxetine 7.5 mg capsuleOralGeneric name | Paroxetine | US FDA | Available on request |
Immunology and transplant
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lenalidomide 10 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Lenalidomide 15 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Lenalidomide 2.5 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Lenalidomide 20 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Lenalidomide 25 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Lenalidomide 5 mg capsuleOralGeneric name | Lenalidomide | US FDA | Available on request |
| Tofacitinib 11 mg extended-release tabletOralGeneric name | Tofacitinib | US FDA | Available on request |
Ophthalmology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Acetylcysteine 6000 mg/30 mL injectionIntravenousGeneric name | Acetylcysteine | US FDA | Available on request |
| Brinzolamide 10 mg/mL ophthalmic suspensionOphthalmicGeneric name | Brinzolamide | US FDA | Available on request |
| Loteprednol etabonate 2 mg/mL ophthalmic suspensionOphthalmicGeneric name | Loteprednol etabonate | US FDA | Available on request |
| Loteprednol etabonate 5 mg/mL ophthalmic suspensionOphthalmicGeneric name | Loteprednol etabonate | US FDA | Available on request |
| Methazolamide 25 mg tabletOralGeneric name | Methazolamide | US FDA | Available on request |
Dermatology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ciclopirox 0.77% gelTopicalGeneric name | Ciclopirox | US FDA | Available on request |
| Clotrimazole 10 mg lozengeOralGeneric name | Clotrimazole | US FDA | Available on request |
| Nystop 100000 units/g topical powderTopical | Nystatin | US FDA | Available on request |
| Podofilox 0.5% gelTopicalGeneric name | Podofilox | US FDA | Available on request |
| Podofilox 5 mg/mL topical solutionTopicalGeneric name | Podofilox | US FDA | Available on request |
Pain and anaesthesia
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Hydromorphone 12 mg extended-release tabletOralGeneric name | Hydromorphone | US FDA | Available on request |
| Hydromorphone 16 mg extended-release tabletOralGeneric name | Hydromorphone | US FDA | Available on request |
| Hydromorphone 32 mg extended-release tabletOralGeneric name | Hydromorphone | US FDA | Available on request |
| Hydromorphone 8 mg extended-release tabletOralGeneric name | Hydromorphone | US FDA | Available on request |
| Lidocaine and Prilocaine 25 mg/25 mg per g creamTopicalGeneric name | Lidocaine and Prilocaine | US FDA | Available on request |
Oncology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tretinoin 0.01% gelTopicalGeneric name | Tretinoin | US FDA | Available on request |
| Tretinoin 0.025% creamTopicalGeneric name | Tretinoin | US FDA | Available on request |
| Tretinoin 0.025% gelTopicalGeneric name | Tretinoin | US FDA | Available on request |
| Tretinoin 0.05% creamTopicalGeneric name | Tretinoin | US FDA | Available on request |
| Tretinoin 0.1% creamTopicalGeneric name | Tretinoin | US FDA | Available on request |
Nephrology and urology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Flavoxate 100 mg tabletOralGeneric name | Flavoxate | US FDA | Available on request |
| Trospium 20 mg tabletOralGeneric name | Trospium | US FDA | Available on request |
| Trospium 60 mg extended-release capsuleOralGeneric name | Trospium | US FDA | Available on request |
Cardiology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Amiloride 5 mg tabletOralGeneric name | Amiloride | US FDA | Available on request |
| Spironolactone 25 mg/5 mL oral suspensionOralGeneric name | Spironolactone | US FDA | Available on request |
Neurology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bromocriptine 2.5 mg tabletOralGeneric name | Bromocriptine | US FDA | Available on request |
Respiratory
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Budesonide 3 mg capsuleOralGeneric name | Budesonide | US FDA | Available on request |
Haematology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Phytonadione 5 mg tabletOralGeneric name | Phytonadione | US FDA | Available on request |
Other products
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Benazepril and Hydrochlorothiazide 20 mg/12.5 mg tabletOralGeneric name | Benazepril and Hydrochlorothiazide | US FDA | Available on request |
| Benazepril and Hydrochlorothiazide 20 mg/25 mg tabletOralGeneric name | Benazepril and Hydrochlorothiazide | US FDA | Available on request |
| Brompheniramine, Dextromethorphan and Pseudoephedrine 2 mg/10 mg/30 mg per 5 mL syrupOralGeneric name | Brompheniramine, Dextromethorphan and Pseudoephedrine | US FDA | Available on request |
| Dexamethasone and Tobramycin 1 mg/3 mg per mL ophthalmic suspensionOphthalmicGeneric name | Dexamethasone and Tobramycin | US FDA | Available on request |
| Evamist 1.53 mg topical sprayTransdermal | Estradiol | US FDA | Available on request |
| Testosterone cypionate 200 mg/1 mL injectionIntramuscularGeneric name | Testosterone cypionate | US FDA | Available on request |
| Testosterone cypionate 2000 mg/10 mL injectionIntramuscularGeneric name | Testosterone cypionate | US FDA | Available on request |
Molecules made
AcetylcysteineAmilorideBenazepril and HydrochlorothiazideBrinzolamideBromocriptineBrompheniramine, Dextromethorphan and PseudoephedrineBudesonideCiclopiroxClotrimazoleProchlorperazineDexamethasone and TobramycinEstradiolFlavoxateHydromorphoneLenalidomideLidocaine and PrilocaineLoteprednol etabonateMethazolamideMethylphenidateMidazolamNystatinParoxetinePhytonadionePodofiloxSpironolactoneTestosterone cypionateTofacitinibTretinoinTrospium
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Padagis
Send a request for any of these products. We confirm the licensed source, documents and lead time.